A Practical Approach to Translating Recent SGLT2 Data into Community Practice
Jeremy Gilbert, MD, FRCPC
Topics: SGLT2 Inhibitors
Details
Objectives
- Review the evidence based on recent clinical trials and the Diabetes Canada Guidelines of the role of SGLT2 inhibitors in clinical practice.
- Discuss the potential site affects of SGLT2 inhibitors and how to counsel your people on ways to minimize risk.
- Integrate the use of SGLT2i inhibitors in a practical manner in clinical practice using case examples.
Faculty
Jeremy Gilbert MD, FRCPC
Program Director, Adult Endocrinology and Metabolism
Sunnybrook Health Sciences Centre
Dr. Gilbert is heavily involved in the management, advancement and continuing medical education of Diabetes. Jeremy completed his medical degree, internal medicine training and endocrinology residency at the University of Toronto. He is an associate professor at the University of Toronto. He is the program director for adult endocrinology and metabolism at the University of Toronto. He has authored a chapter in the 2013 and 2018 Diabetes Canada Guidelines and was a member of the steering committee of the 2018 Diabetes Canada Guidelines. He is on the executive and is a national editor for the Canadian Journal of Diabetes. He is a passionate teacher and his academic interest is in undergraduate, postgraduate and continuing medical education in diabetes and endocrinology. He has received numerous awards for outstanding teaching.